• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Jim Cramer Recommends Buying Apple, Finds This Tech Stock 'Very Interesting'

    5/29/24 8:47:14 AM ET
    $AAPL
    $ACLS
    $CRM
    $DDOG
    Computer Manufacturing
    Technology
    Industrial Machinery/Components
    Technology
    Get the next $AAPL alert in real time by email

    On CNBC's “Mad Money Lightning Round,” Jim Cramer said Apple Inc. (NASDAQ:AAPL) is a “buy here.”

    Apple's iPhone sales in China increased by 52% year-on-year in April, Reuters cited from industry reports.

    When asked about Palantir Technologies Inc. (NYSE:PLTR), he said, “It's very tough to understand what they really do for the government. So, therefore, I am no longer going to say that that's a stock to own.”

    On May 6, Palantir said first-quarter revenue increased 21% year-over-year to $634 million, which beat the consensus estimate of $625.431 million.

    Axcelis Technologies, Inc. (NASDAQ:ACLS) is a “very good semiconductor that's been left behind,” Cramer said. “I find that very interesting.”

    On May 1, Axcelis Technologies posted better-than-expected quarterly results.

    When asked about Datadog, Inc. (NASDAQ:DDOG), Cramer said he wants quarterly earnings report from Salesforce (NYSE:CRM) today, as Workday (NASDAQ:WDAY) was “not as good as I'd like.” He added, “If Salesforce is not as good as I'd like, then Datadog's going to go down. Let's hold off for a day.”

    On May 15, Needham analyst Mike Cikos reiterated Datadog with a Buy and maintained a $165 price target.

    Cramer said Novo Nordisk A/S (NYSE:NVO) is a “good growth” stock, but he likes Eli Lilly and Company (NYSE:LLY) better.

    Novo Nordisk disclosed that it retains approximately 60% of the list price of its diabetes and obesity medications, Ozempic and Wegovy, in the U.S. after accounting for rebates and fees paid to intermediaries.

    T. Rowe Price Group, Inc. (NASDAQ:TROW) is “such a bargain,” the “Mad Money” host said. “I'd love to join you in owning that one.”

    On April 26, T. Rowe Price posted better-than-expected financial results for the first quarter.

    Jim Cramer said he needs to do some more work on Great Lakes Dredge & Dock Corporation (NASDAQ:GLDD).

    On May 7, Great Lakes Dredge & Docks posted better-than-expected first-quarter financial results.

    “This is TV stations, and I just don't care for anything involving linear TV,” Cramer said when asked about TEGNA Inc. (NYSE:TGNA).

    On May 8, Tegna posted stronger-than-expected quarterly earnings.

    Price Action:

    • Datadog shares fell 1.2% to settle at $122.11 on Tuesday.
    • T. Rowe Price shares fell 1.6% to close at $116.33.
    • Palantir Technologies shares rose 0.2% to settle at $21.05.
    • Axcelis Technologies shares gained 3.6% to close at $115.33 on Tuesday.
    • Tegna shares gained 0.6% to settle at $14.42.
    • Apple shares rose 0.01% to settle at $189.99 on Tuesday.
    • Novo Nordisk shares fell 1.4% to settle at $134.08 during Tuesday's session.
    • Great Lakes Dredge & Dock shares gained 0.3% to close at $9.23 on Tuesday.

    Read Next: Advance Auto Parts, Ooma And 3 Stocks To Watch Heading Into Wednesday

    Image: Shutterstock

    Get the next $AAPL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAPL
    $ACLS
    $CRM
    $DDOG

    CompanyDatePrice TargetRatingAnalyst
    Palantir Technologies Inc.
    $PLTR
    2/10/2026$180.00Neutral → Buy
    Daiwa Securities
    Apple Inc.
    $AAPL
    2/10/2026$325.00 → $340.00Outperform
    Bernstein
    Palantir Technologies Inc.
    $PLTR
    2/3/2026$205.00Hold → Buy
    HSBC Securities
    Palantir Technologies Inc.
    $PLTR
    2/3/2026$190.00Market Perform → Outperform
    Northland Capital
    Palantir Technologies Inc.
    $PLTR
    2/3/2026$200.00Neutral → Outperform
    Robert W. Baird
    Palantir Technologies Inc.
    $PLTR
    2/2/2026Mkt Perform → Outperform
    William Blair
    Apple Inc.
    $AAPL
    1/30/2026$315.00 → $325.00Overweight
    Analyst
    Apple Inc.
    $AAPL
    1/30/2026$230.00 → $239.00Underweight
    Barclays
    More analyst ratings

    $AAPL
    $ACLS
    $CRM
    $DDOG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Palantir Technologies upgraded by Daiwa Securities with a new price target

    Daiwa Securities upgraded Palantir Technologies from Neutral to Buy and set a new price target of $180.00

    2/10/26 7:57:53 AM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    Bernstein reiterated coverage on Apple with a new price target

    Bernstein reiterated coverage of Apple with a rating of Outperform and set a new price target of $340.00 from $325.00 previously

    2/10/26 7:51:49 AM ET
    $AAPL
    Computer Manufacturing
    Technology

    Palantir Technologies upgraded by HSBC Securities with a new price target

    HSBC Securities upgraded Palantir Technologies from Hold to Buy and set a new price target of $205.00

    2/3/26 12:10:56 PM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    $AAPL
    $ACLS
    $CRM
    $DDOG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Kirk David Blair bought $500,722 worth of shares (1,936 units at $258.64), increasing direct ownership by 22% to 10,677 units (SEC Form 4)

    4 - Salesforce, Inc. (0001108524) (Issuer)

    12/18/25 5:10:12 PM ET
    $CRM
    Computer Software: Prepackaged Software
    Technology

    Director Morfit G Mason bought $25,015,680 worth of shares (96,000 units at $260.58) (SEC Form 4)

    4 - Salesforce, Inc. (0001108524) (Issuer)

    12/8/25 9:30:14 AM ET
    $CRM
    Computer Software: Prepackaged Software
    Technology

    Director Kirk David Blair bought $865,827 worth of shares (3,400 units at $254.66), gifted 4,278 shares and received a gift of 4,278 shares, increasing direct ownership by 1,811% to 8,102 units (SEC Form 4)

    4 - Salesforce, Inc. (0001108524) (Issuer)

    9/10/25 7:45:16 PM ET
    $CRM
    Computer Software: Prepackaged Software
    Technology

    $AAPL
    $ACLS
    $CRM
    $DDOG
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    September 17, 2024 - FDA Roundup: September 17, 2024

    For Immediate Release: September 17, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued a draft guidance, “Integrating Randomized Controlled Trials for Drug and Biological Products into Routine Clinical Practice,” which, when finalized, will support the conduct of randomized controlled trials with streamlined protocols a

    9/17/24 2:34:22 PM ET
    $AAPL
    Computer Manufacturing
    Technology

    September 12, 2024 - FDA Authorizes First Over-the-Counter Hearing Aid Software

    For Immediate Release: September 12, 2024 Today, the U.S. Food and Drug Administration authorized the first over-the-counter (OTC) hearing aid software device, Hearing Aid Feature, intended to be used with compatible versions of the Apple AirPods Pro headphones. Once installed and customized to the user’s hearing needs, the Hearing Aid Feature enables compatible versions of the AirPods Pro to serve as an OTC hea

    9/12/24 10:58:17 AM ET
    $AAPL
    Computer Manufacturing
    Technology

    May 31, 2024 - FDA Roundup: May 31, 2024

    For Immediate Release: May 31, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA approved mRESVIA (Respiratory Syncytial Virus Vaccine) for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older. mRESVIA is an mRNA-based vaccine that is manufa

    5/31/24 3:22:42 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAPL
    $ACLS
    $CRM
    $DDOG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight

    The EGFR-NSCLC market is expected to grow owing to the approval of new agents such as Zipalertinib (Cullinan Oncology/Taiho Pharma), Ivonescimab (Akeso Biopharma/Summit Therapeutics), Sacituzumab Tirumotecan (Merck/Kelun-Biotech), Izalontamab Brengitecan (Bristol-Myers Squibb), Firmonertinib (ArriVent BioPharma), and others in frontline and combination settings, rising therapy costs, and increasing testing rates that enable the identification of more patients with EGFR alterations. LAS VEGAS, Feb. 11, 2026 /PRNewswire/ -- DelveInsight's EGFR-NSCLC Market Insights report includes a comprehensive understanding of current treatment practices, EGFR-NSCLC emerging drugs, market share of individua

    2/11/26 5:31:00 PM ET
    $ABBV
    $AVBP
    $BDTX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    /C O R R E C T I O N -- T. Rowe Price Group/

    In the news release, T. ROWE PRICE GROUP REPORTS MONTH-END ASSETS UNDER MANAGEMENT FOR JANUARY 2026, issued 11-Feb-2026 by T. Rowe Price Group over PR Newswire, the original version contained incorrect information introduced by PR Newswire during transmission. The complete, corrected release follows, with additional details at the end: T. ROWE PRICE GROUP REPORTS MONTH-END ASSETS UNDER MANAGEMENT FOR JANUARY 2026 BALTIMORE, Feb. 11, 2026 /PRNewswire/ -- T. Rowe Price Group, Inc. (NASDAQ-GS: TROW) announced January month-end assets under management of $1.80 trillion. Net outflows for January 2026 were $5.2 billion.

    2/11/26 8:30:00 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    T. ROWE PRICE: RETIREMENT SAVERS USING FINANCIAL ADVICE, EDUCATION, OR TOOLS HAVE TWICE THE AVERAGE ACCOUNT BALANCE THAN NON-USERS

    Firm's annual 401(k) benchmarking report reveals how advice and plan design can help drive better retirement outcomes BALTIMORE, Feb. 11, 2026 /PRNewswire/ -- T. Rowe Price, a global asset management firm and a leader in retirement, today released its annual 401(k) benchmarking report, Reference Point, featuring the latest trends and insights in plan design and participant behavior. This year's report spotlights a standout finding: participants who engage with the financial advice, education, or tools available through their workplace retirement site save at a rate that is 29% higher than non-users and have twice the average account balance. Meanwhile, only 13.8% of participants currently u

    2/11/26 10:00:00 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    $AAPL
    $ACLS
    $CRM
    $DDOG
    SEC Filings

    View All

    SEC Form SC14D9C filed by Great Lakes Dredge & Dock Corporation

    SC14D9C - Great Lakes Dredge & Dock CORP (0001372020) (Subject)

    2/11/26 4:09:52 PM ET
    $GLDD
    Military/Government/Technical
    Industrials

    SEC Form 6-K filed by Novo Nordisk A/S

    6-K - NOVO NORDISK A S (0000353278) (Filer)

    2/11/26 4:09:13 PM ET
    $NVO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Great Lakes Dredge & Dock Corporation filed SEC Form 8-K: Regulation FD Disclosure

    8-K - Great Lakes Dredge & Dock CORP (0001372020) (Filer)

    2/11/26 7:37:52 AM ET
    $GLDD
    Military/Government/Technical
    Industrials

    $AAPL
    $ACLS
    $CRM
    $DDOG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Finance, & CAO Zakrowski Donald A was granted 584 shares, increasing direct ownership by 21% to 3,423 units (SEC Form 4)

    4 - ELI LILLY & Co (0000059478) (Issuer)

    2/11/26 4:27:28 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP&Pres, LLY USA&Global Capab Yuffa Ilya was granted 4,163 shares, increasing direct ownership by 15% to 32,304 units (SEC Form 4)

    4 - ELI LILLY & Co (0000059478) (Issuer)

    2/11/26 4:26:05 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP,Pres LLY Oncology&HdCorpBD Van Naarden Jacob was granted 4,866 shares, increasing direct ownership by 22% to 26,626 units (SEC Form 4)

    4 - ELI LILLY & Co (0000059478) (Issuer)

    2/11/26 4:25:13 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAPL
    $ACLS
    $CRM
    $DDOG
    Leadership Updates

    Live Leadership Updates

    View All

    Great Lakes Dredge & Dock to Join the Saltchuk Family of Companies

    HOUSTON and SEATTLE, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Great Lakes Dredge & Dock Corporation ("Great Lakes" or the "Company") (NASDAQ:GLDD), the largest provider of dredging services in the United States, and Saltchuk Resources, Inc. ("Saltchuk"), a privately owned family of diversified freight transportation, marine service, and energy distribution companies, today announced a definitive agreement for Saltchuk to acquire Great Lakes at an aggregate equity value of approximately $1.2 billion and a total transaction value of $1.5 billion. Under the terms of the agreement, which has been unanimously approved by the Board of Directors of both companies, Saltchuk will commence a tender offer

    2/11/26 7:30:00 AM ET
    $GLDD
    Military/Government/Technical
    Industrials

    Workday Announces CEO Transition as Co-Founder Aneel Bhusri Returns to Lead the Company's Next Chapter

    Carl Eschenbach Steps Down After Leading Company Through a Period of Global Expansion and Operational Scale Company Reaffirms Fiscal 2026 Fourth Quarter and Full-Year Outlook PLEASANTON, Calif., Feb. 9, 2026 /PRNewswire/ -- Workday, Inc. (NASDAQ:WDAY), the enterprise AI platform for managing people, money, and agents, today announced that co-founder and current executive chair Aneel Bhusri is returning as chief executive officer as the company enters its next chapter, focused on leading in the rapidly evolving AI era. Carl Eschenbach is stepping down as CEO and as a member of the board after leading Workday through a period defined by global growth, an expanded industry focus, and strengthen

    2/9/26 8:30:00 AM ET
    $WDAY
    EDP Services
    Technology

    Lilly to acquire Orna Therapeutics to advance cell therapies

    Orna's in vivo CAR-T pipeline includes potential best-in-class programs to reset the immune system and address B cell-driven autoimmune diseases Acquisition provides a broad platform for long-term innovation in genetic medicine and in vivo cell engineering INDIANAPOLIS and WATERTOWN, Mass., Feb. 9, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Orna Therapeutics, Inc., a biotechnology company dedicated to engineering immune cells in vivo, today announced entry into a definitive agreement for Lilly to acquire Orna. Orna is advancing a new class of therapeutics utilizing engineered circular RNA paired with novel lipid nanoparticles to allow the patient's own body to generate cell

    2/9/26 7:00:00 AM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAPL
    $ACLS
    $CRM
    $DDOG
    Financials

    Live finance-specific insights

    View All

    Great Lakes Dredge & Dock Corporation Schedules Announcement of 2025 Fourth Quarter and Full Year 2025 Results

    HOUSTON, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Great Lakes Dredge & Dock Corporation (NASDAQ:GLDD) today announced that it will release the financial results for its three and twelve months ended December 31, 2025, on Tuesday, February 17, 2026, at 7:00 a.m. C.S.T. A conference call with the Company will be held the same day at 9:00 a.m. C.S.T. Investors and analysts are encouraged to pre-register for the conference call by using the link below. Participants who pre-register will be given a unique PIN to gain immediate access to the call. Pre-registration may be completed at any time up to the call start time. To pre-register, go to https://register-conf.media-server.com/register/BI2c318ee40

    2/10/26 8:00:00 AM ET
    $GLDD
    Military/Government/Technical
    Industrials

    Datadog Announces Fourth Quarter and Fiscal Year 2025 Financial Results

    Fourth quarter revenue grew 29% year-over-year to $953 million Strong growth of larger customers, with 603 $1 million+ ARR customers, up from 462 a year ago Launched Bits AI SRE Agent, Storage Management, Feature Flags, and Data Observability for general availability NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Datadog, Inc. (NASDAQ:DDOG), the AI-powered observability and security platform for cloud applications, today announced financial results for its fourth quarter and fiscal year ended December 31, 2025. "We are pleased with our strong execution in fiscal year 2025, with 28% year-over-year revenue growth, $1,050 million in operating cash flow, and $915 milli

    2/10/26 7:00:00 AM ET
    $DDOG
    Computer Software: Prepackaged Software
    Technology

    Salesforce Announces Timing of its Fourth Quarter and Full Year Fiscal 2026 Results Conference Call

    Results to be released on February 25, 2026, after market close Salesforce (NYSE:CRM), the world's #1 AI CRM, today announced that its fourth quarter and full year fiscal 2026 results will be released on Wednesday, February 25, 2026, after the close of the market. The company will host a conference call at 2:00 p.m. (PT) / 5:00 p.m. (ET) to discuss its financial results with the investment community. A live webcast and replay of the event will be available on the Salesforce Investor Relations website at www.salesforce.com/investor. About Salesforce Salesforce helps organizations of any size become agentic enterprises — integrating humans, agents, apps, and data on a trusted, unified p

    2/4/26 4:30:00 PM ET
    $CRM
    Computer Software: Prepackaged Software
    Technology

    $AAPL
    $ACLS
    $CRM
    $DDOG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Palantir Technologies Inc.

    SC 13G/A - Palantir Technologies Inc. (0001321655) (Subject)

    11/14/24 5:47:09 PM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Salesforce Inc.

    SC 13G/A - Salesforce, Inc. (0001108524) (Subject)

    11/14/24 1:22:34 PM ET
    $CRM
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by TEGNA Inc

    SC 13G/A - TEGNA INC (0000039899) (Subject)

    11/12/24 5:55:50 PM ET
    $TGNA
    Broadcasting
    Industrials